Became director of the MRC Experimental Radiopathology Unit at Hammersmith Hospital, leading major radiation biology research.
In 1962, Tikvah Alper became director of the Medical Research Council Experimental Radiopathology Unit at Hammersmith Hospital in London. This appointment marked a major professional milestone, placing her in charge of a research unit at a leading British medical center and confirming her standing as a radiobiologist of international importance.
Her directorship was significant because it represented the culmination of years of work carried out under difficult conditions after her arrival in the United Kingdom. At Hammersmith, she helped shape experimental research on the biological effects of radiation and on the behavior of cells after exposure. In an era when senior scientific leadership remained overwhelmingly male, her appointment demonstrated both scientific authority and institutional trust.
Alper held this post through the early 1970s, and her leadership contributed to the broader development of radiation biology as a field. The unit’s work helped clarify how cells respond to damage and how radiation can produce complex biological effects. Her directorship is also remembered as a marker of how a woman scientist who had been excluded from formal opportunities in South Africa went on to lead a major research program in Britain.